Concepedia

A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas

R. Landgraf, H. J. G. Bilo, P. G. Müller

European Journal of Clinical Pharmacology · 1999 · 92 citations · 3 references

DOI

Concepts

References

3

Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.

Jannie Fuhlendorff, Patrik Rorsman, Hans Kofod et al. · Diabetes · 1998 · 313 citations

, , +16

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM

Bruce H. R. Wolffenbuttel, L. Nijst, J P Sels et al. · European Journal of Clinical Pharmacology · 1993 · 84 citations

, , +11

Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.

Vibeke Hatorp, S. Oliver, C-S Su · PubMed · 1998 · 63 citations

, , +17